143 related articles for article (PubMed ID: 36216791)
1. Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib.
Kittai AS; Huang Y; Beckwith KA; Bhat SA; Bond DA; Byrd JC; Goldstein D; Grever MR; Miller C; Rogers KA; Yano M; Woyach JA
Am J Hematol; 2023 Jan; 98(1):56-65. PubMed ID: 36216791
[TBL] [Abstract][Full Text] [Related]
2. Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy.
Mato AR; Wierda WG; Davids MS; Cheson BD; Coutre SE; Choi M; Furman RR; Heffner L; Barr PM; Eradat H; Ford SM; Zhou L; Verdugo M; Humerickhouse RA; Potluri J; Byrd JC
Haematologica; 2019 Nov; 104(11):2258-2264. PubMed ID: 30923097
[TBL] [Abstract][Full Text] [Related]
3. Detection of Richter's transformation of chronic lymphocytic leukemia by PET/CT.
Bruzzi JF; Macapinlac H; Tsimberidou AM; Truong MT; Keating MJ; Marom EM; Munden RF
J Nucl Med; 2006 Aug; 47(8):1267-73. PubMed ID: 16883004
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
Elnair R; Ellithi M; Kallam A; Shostrom V; Bociek RG
Ann Hematol; 2021 Oct; 100(10):2513-2519. PubMed ID: 34279675
[TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study.
Hleuhel MH; Ben-Dali Y; Da Cunha-Bang C; Brieghel C; Clasen-Linde E; Niemann CU; Andersen MA
BMJ Open; 2019 Mar; 9(3):e023566. PubMed ID: 30833314
[TBL] [Abstract][Full Text] [Related]
6. Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia.
Maddocks KJ; Ruppert AS; Lozanski G; Heerema NA; Zhao W; Abruzzo L; Lozanski A; Davis M; Gordon A; Smith LL; Mantel R; Jones JA; Flynn JM; Jaglowski SM; Andritsos LA; Awan F; Blum KA; Grever MR; Johnson AJ; Byrd JC; Woyach JA
JAMA Oncol; 2015 Apr; 1(1):80-7. PubMed ID: 26182309
[TBL] [Abstract][Full Text] [Related]
7. PET/Computed Tomography in Chronic Lymphocytic Leukemia and Richter Transformation.
Rhodes JM; Mato AR
PET Clin; 2019 Jul; 14(3):405-410. PubMed ID: 31084779
[TBL] [Abstract][Full Text] [Related]
8. Richter's transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study.
Ben-Dali Y; Hleuhel MH; da Cunha-Bang C; Brieghel C; Poulsen CB; Clasen-Linde E; Bentzen HHN; Frederiksen H; Christiansen I; Nielsen LH; Enggaard L; Helleberg M; Clausen M; Frederiksen M; Pedersen RS; Niemann CU; Andersen MA
Leuk Lymphoma; 2020 Jun; 61(6):1435-1444. PubMed ID: 32031030
[TBL] [Abstract][Full Text] [Related]
9. B-chronic lymphocytic leukemia showed triple transformation, to diffuse large B cell, CD20-negative, and T-cell neoplasm during ofatumumab treatment: a case report.
Imataki O; Uemura M
BMC Clin Pathol; 2018; 18():5. PubMed ID: 29796007
[TBL] [Abstract][Full Text] [Related]
10. Richter's transformation in chronic lymphocytic leukemia.
Jain P; O'Brien S
Oncology (Williston Park); 2012 Dec; 26(12):1146-52. PubMed ID: 23413591
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin Lymphoma Transformation of Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: Chance Association or Therapy-related?
Sachanas S; Pangalis GA; Moschogiannis M; Yiakoumis X; Koulieris E; Tsirkinidis P; Kalpadakis C; Rontogianni D
Anticancer Res; 2017 Jun; 37(6):3277-3280. PubMed ID: 28551676
[TBL] [Abstract][Full Text] [Related]
12. An Unusual Presentation of Richter's Transformation of Chronic Lymphocytic Leukemia in Liver and Lung on
Sood A; Parihar AS; Lad D; Kumar R; Singh H; Mittal BR
Indian J Nucl Med; 2020; 35(1):70-71. PubMed ID: 31949376
[TBL] [Abstract][Full Text] [Related]
13. Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study.
Younes A; Brody J; Carpio C; Lopez-Guillermo A; Ben-Yehuda D; Ferhanoglu B; Nagler A; Ozcan M; Avivi I; Bosch F; Caballero Barrigón MD; Hellmann A; Kuss B; Ma DDF; Demirkan F; Yağci M; Horowitz NA; Marlton P; Cordoba R; Wrobel T; Buglio D; Streit M; Hodkinson BP; Schaffer M; Alvarez J; Ceulemans R; Balasubramanian S; de Jong J; Wang SS; Fourneau N; Jurczak W
Lancet Haematol; 2019 Feb; 6(2):e67-e78. PubMed ID: 30642819
[TBL] [Abstract][Full Text] [Related]
14. Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study.
O'Brien S; Jones JA; Coutre SE; Mato AR; Hillmen P; Tam C; Österborg A; Siddiqi T; Thirman MJ; Furman RR; Ilhan O; Keating MJ; Call TG; Brown JR; Stevens-Brogan M; Li Y; Clow F; James DF; Chu AD; Hallek M; Stilgenbauer S
Lancet Oncol; 2016 Oct; 17(10):1409-1418. PubMed ID: 27637985
[TBL] [Abstract][Full Text] [Related]
15. Early Transformation to Classic Hodgkin Lymphoma in a Chemotherapy-naïve Chronic Lymphocytic Leukemia Patient upon Initial Treatment with Ibrutinib.
Koshiishi M; Odate T; Nakagawa Y; Suzuki J; Kumagai T; Kawashima I; Yamamoto T; Nakajima K; Tanaka M; Oishi N; Kondo T; Kirito K
Intern Med; 2021 Oct; 60(20):3305-3308. PubMed ID: 33896865
[TBL] [Abstract][Full Text] [Related]
16. An experience with ibrutinib monotherapy for Richter's syndrome isolated in the central nervous system.
Nato Y; Nagaharu K; Inoue K; Yabu K; Sawaki A; Shiotani T; Kageyama Y; Tanaka K; Ohshima K; Miyashita H
J Clin Exp Hematop; 2022 Dec; 62(4):238-241. PubMed ID: 36436931
[TBL] [Abstract][Full Text] [Related]
17. Richter's syndrome: Utility of ¹⁸F-FDG PET/CT.
García Vicente AM; Jiménez Londoño GA; Hernández Ruiz B; Soriano Castrejón Á
Rev Esp Med Nucl Imagen Mol; 2013 Mar; 32(2):102-4. PubMed ID: 23044071
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes for patients with chronic lymphocytic leukemia who discontinue ibrutinib.
Jain P; Thompson PA; Keating M; Estrov Z; Ferrajoli A; Jain N; Kantarjian H; Burger JA; O'Brien S; Wierda WG
Cancer; 2017 Jun; 123(12):2268-2273. PubMed ID: 28171709
[TBL] [Abstract][Full Text] [Related]
19. Richter's transformation presenting as splenic rupture after 6 years of complete remission of chronic lymphocytic leukaemia.
Thyagarajan B; Alagusundaramoorthy SS; Shah L; Agrawal A
BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27288204
[TBL] [Abstract][Full Text] [Related]
20. A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL.
Jain N; Senapati J; Thakral B; Ferrajoli A; Thompson P; Burger J; Basu S; Kadia T; Daver N; Borthakur G; Konopleva M; Pemmaraju N; Parry E; Wu CJ; Khoury J; Bueso-Ramos C; Garg N; Wang X; Lopez W; Ayala A; O'Brien S; Kantarjian H; Keating M; Allison J; Sharma P; Wierda W
Blood Adv; 2023 May; 7(10):1958-1966. PubMed ID: 36287248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
